Cargando…

Quercetin and/or Ascorbic Acid Modulatory Effect on Phenobarbital-Induced Sleeping Mice Possibly through GABA(A) and GABA(B) Receptor Interaction Pathway

Depressive disorder is a recurrent illness that affects large numbers of the general population worldwide. In recent years, the goal of depression treatment has moved from symptomatic response to that of full remission. However, treatment-resistant depression is a major challenge in the treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hossain, Rajib, Al-Khafaji, Khattab, Khan, Rasel Ahmed, Sarkar, Chandan, Islam, Md. Shahazul, Dey, Dipta, Jain, Divya, Faria, Farhana, Akbor, Rukaya, Atolani, Olubunmi, Oliveira, Sónia M. R., Siyadatpanah, Abolghasem, Pereira, Maria de Lourdes, Islam, Muhammad Torequl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398796/
https://www.ncbi.nlm.nih.gov/pubmed/34451819
http://dx.doi.org/10.3390/ph14080721
_version_ 1783744924088270848
author Hossain, Rajib
Al-Khafaji, Khattab
Khan, Rasel Ahmed
Sarkar, Chandan
Islam, Md. Shahazul
Dey, Dipta
Jain, Divya
Faria, Farhana
Akbor, Rukaya
Atolani, Olubunmi
Oliveira, Sónia M. R.
Siyadatpanah, Abolghasem
Pereira, Maria de Lourdes
Islam, Muhammad Torequl
author_facet Hossain, Rajib
Al-Khafaji, Khattab
Khan, Rasel Ahmed
Sarkar, Chandan
Islam, Md. Shahazul
Dey, Dipta
Jain, Divya
Faria, Farhana
Akbor, Rukaya
Atolani, Olubunmi
Oliveira, Sónia M. R.
Siyadatpanah, Abolghasem
Pereira, Maria de Lourdes
Islam, Muhammad Torequl
author_sort Hossain, Rajib
collection PubMed
description Depressive disorder is a recurrent illness that affects large numbers of the general population worldwide. In recent years, the goal of depression treatment has moved from symptomatic response to that of full remission. However, treatment-resistant depression is a major challenge in the treatment of depression or depression-related disorders. Consensus opinion, therefore, suggests that effective combined aggressive initial treatment is the most appropriate strategy. This study aimed to evaluate the effects of quercetin (QUR) and/or ascorbic acid (AA) on Phenobarbital-induced sleeping mice. QUR (50 mg/kg) and/or AA (25 mg/kg) with or without intraperitoneally pre-treated with GABA receptor agonist (diazepam: 2 mg/kg, i.p.) or antagonist (Flumazenil: 2.5 mg/kg, i.p.) to underscore the effects, as well as the possible involvement of the GABA receptor in the modulatory action of QUR and AA in sleeping mice. Additionally, an in silico study was undertaken to predict the involvement of GABA receptors in the sleep mechanism. Findings suggest that the pretreatment of QUR and AA modulated the onset and duration of action of the standard drugs in experimental animals. The acute administration of QUR and/or AA significantly (p < 0.05) reversed the DZP-mediated onset of action and slightly reversed the duration of sleep time in comparison to the vehicle (control) group. A further combination of QUR or AA with the FLU resulted in an enhancement of the onset of action while reducing the duration of action, suggesting a FLU-like effect on the test animals. In in silico studies, AA and QUR showed good to moderate binding affinities with GABA(A) and GABA(B) receptors. Both QUR and AA produced a stimulatory-like effect on mice, possibly through the GABA(A) and GABA(B) receptor interaction pathways. Further studies are necessary to verify this activity and clarify the exact mechanism of action(s) involved.
format Online
Article
Text
id pubmed-8398796
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83987962021-08-29 Quercetin and/or Ascorbic Acid Modulatory Effect on Phenobarbital-Induced Sleeping Mice Possibly through GABA(A) and GABA(B) Receptor Interaction Pathway Hossain, Rajib Al-Khafaji, Khattab Khan, Rasel Ahmed Sarkar, Chandan Islam, Md. Shahazul Dey, Dipta Jain, Divya Faria, Farhana Akbor, Rukaya Atolani, Olubunmi Oliveira, Sónia M. R. Siyadatpanah, Abolghasem Pereira, Maria de Lourdes Islam, Muhammad Torequl Pharmaceuticals (Basel) Article Depressive disorder is a recurrent illness that affects large numbers of the general population worldwide. In recent years, the goal of depression treatment has moved from symptomatic response to that of full remission. However, treatment-resistant depression is a major challenge in the treatment of depression or depression-related disorders. Consensus opinion, therefore, suggests that effective combined aggressive initial treatment is the most appropriate strategy. This study aimed to evaluate the effects of quercetin (QUR) and/or ascorbic acid (AA) on Phenobarbital-induced sleeping mice. QUR (50 mg/kg) and/or AA (25 mg/kg) with or without intraperitoneally pre-treated with GABA receptor agonist (diazepam: 2 mg/kg, i.p.) or antagonist (Flumazenil: 2.5 mg/kg, i.p.) to underscore the effects, as well as the possible involvement of the GABA receptor in the modulatory action of QUR and AA in sleeping mice. Additionally, an in silico study was undertaken to predict the involvement of GABA receptors in the sleep mechanism. Findings suggest that the pretreatment of QUR and AA modulated the onset and duration of action of the standard drugs in experimental animals. The acute administration of QUR and/or AA significantly (p < 0.05) reversed the DZP-mediated onset of action and slightly reversed the duration of sleep time in comparison to the vehicle (control) group. A further combination of QUR or AA with the FLU resulted in an enhancement of the onset of action while reducing the duration of action, suggesting a FLU-like effect on the test animals. In in silico studies, AA and QUR showed good to moderate binding affinities with GABA(A) and GABA(B) receptors. Both QUR and AA produced a stimulatory-like effect on mice, possibly through the GABA(A) and GABA(B) receptor interaction pathways. Further studies are necessary to verify this activity and clarify the exact mechanism of action(s) involved. MDPI 2021-07-26 /pmc/articles/PMC8398796/ /pubmed/34451819 http://dx.doi.org/10.3390/ph14080721 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hossain, Rajib
Al-Khafaji, Khattab
Khan, Rasel Ahmed
Sarkar, Chandan
Islam, Md. Shahazul
Dey, Dipta
Jain, Divya
Faria, Farhana
Akbor, Rukaya
Atolani, Olubunmi
Oliveira, Sónia M. R.
Siyadatpanah, Abolghasem
Pereira, Maria de Lourdes
Islam, Muhammad Torequl
Quercetin and/or Ascorbic Acid Modulatory Effect on Phenobarbital-Induced Sleeping Mice Possibly through GABA(A) and GABA(B) Receptor Interaction Pathway
title Quercetin and/or Ascorbic Acid Modulatory Effect on Phenobarbital-Induced Sleeping Mice Possibly through GABA(A) and GABA(B) Receptor Interaction Pathway
title_full Quercetin and/or Ascorbic Acid Modulatory Effect on Phenobarbital-Induced Sleeping Mice Possibly through GABA(A) and GABA(B) Receptor Interaction Pathway
title_fullStr Quercetin and/or Ascorbic Acid Modulatory Effect on Phenobarbital-Induced Sleeping Mice Possibly through GABA(A) and GABA(B) Receptor Interaction Pathway
title_full_unstemmed Quercetin and/or Ascorbic Acid Modulatory Effect on Phenobarbital-Induced Sleeping Mice Possibly through GABA(A) and GABA(B) Receptor Interaction Pathway
title_short Quercetin and/or Ascorbic Acid Modulatory Effect on Phenobarbital-Induced Sleeping Mice Possibly through GABA(A) and GABA(B) Receptor Interaction Pathway
title_sort quercetin and/or ascorbic acid modulatory effect on phenobarbital-induced sleeping mice possibly through gaba(a) and gaba(b) receptor interaction pathway
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398796/
https://www.ncbi.nlm.nih.gov/pubmed/34451819
http://dx.doi.org/10.3390/ph14080721
work_keys_str_mv AT hossainrajib quercetinandorascorbicacidmodulatoryeffectonphenobarbitalinducedsleepingmicepossiblythroughgabaaandgababreceptorinteractionpathway
AT alkhafajikhattab quercetinandorascorbicacidmodulatoryeffectonphenobarbitalinducedsleepingmicepossiblythroughgabaaandgababreceptorinteractionpathway
AT khanraselahmed quercetinandorascorbicacidmodulatoryeffectonphenobarbitalinducedsleepingmicepossiblythroughgabaaandgababreceptorinteractionpathway
AT sarkarchandan quercetinandorascorbicacidmodulatoryeffectonphenobarbitalinducedsleepingmicepossiblythroughgabaaandgababreceptorinteractionpathway
AT islammdshahazul quercetinandorascorbicacidmodulatoryeffectonphenobarbitalinducedsleepingmicepossiblythroughgabaaandgababreceptorinteractionpathway
AT deydipta quercetinandorascorbicacidmodulatoryeffectonphenobarbitalinducedsleepingmicepossiblythroughgabaaandgababreceptorinteractionpathway
AT jaindivya quercetinandorascorbicacidmodulatoryeffectonphenobarbitalinducedsleepingmicepossiblythroughgabaaandgababreceptorinteractionpathway
AT fariafarhana quercetinandorascorbicacidmodulatoryeffectonphenobarbitalinducedsleepingmicepossiblythroughgabaaandgababreceptorinteractionpathway
AT akborrukaya quercetinandorascorbicacidmodulatoryeffectonphenobarbitalinducedsleepingmicepossiblythroughgabaaandgababreceptorinteractionpathway
AT atolaniolubunmi quercetinandorascorbicacidmodulatoryeffectonphenobarbitalinducedsleepingmicepossiblythroughgabaaandgababreceptorinteractionpathway
AT oliveirasoniamr quercetinandorascorbicacidmodulatoryeffectonphenobarbitalinducedsleepingmicepossiblythroughgabaaandgababreceptorinteractionpathway
AT siyadatpanahabolghasem quercetinandorascorbicacidmodulatoryeffectonphenobarbitalinducedsleepingmicepossiblythroughgabaaandgababreceptorinteractionpathway
AT pereiramariadelourdes quercetinandorascorbicacidmodulatoryeffectonphenobarbitalinducedsleepingmicepossiblythroughgabaaandgababreceptorinteractionpathway
AT islammuhammadtorequl quercetinandorascorbicacidmodulatoryeffectonphenobarbitalinducedsleepingmicepossiblythroughgabaaandgababreceptorinteractionpathway